Literature DB >> 11150500

Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110.

A Pavlova1, J C Krupa, J S Mort, M Abrahamson, I Björk.   

Abstract

Cystatins A and C were both shown to inhibit cathepsin B by a two-step mechanism, involving an initial weak interaction followed by a conformational change. Disruption of the major salt bridge anchoring the occluding loop of cathepsin B to the main body of the enzyme by mutation of His110 to Ala converted the binding to an apparent one-step reaction. The second step of cystatin binding to cathepsin B must therefore be due to the inhibitor having to alter the conformation of the enzyme by displacing the occluding loop to allow a tight complex to be formed. Cystatin A was appreciably less effective in displacing the loop than cystatin C, resulting in a considerably lower overall inhibition rate constant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150500     DOI: 10.1016/s0014-5793(00)02337-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle.

Authors:  Eric J Stevenson; Paul G Giresi; Alan Koncarevic; Susan C Kandarian
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

2.  S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Authors:  Joanne C Krupa; Sadiq Hasnain; Dorit K Nägler; Robert Ménard; John S Mort
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Inhibition of mammalian cathepsins by Plesiomonas shigelloides.

Authors:  A Pavlova; K Krovácek; I Ciznár; C Gonzalez-Rey
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

Review 5.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

6.  Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.

Authors:  E Pol; I Björk
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

7.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

8.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

9.  Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling.

Authors:  Napoleão F Valadares; Márcia Dellamano; Andrea Soares-Costa; Flávio Henrique-Silva; Richard C Garratt
Journal:  BMC Struct Biol       Date:  2010-09-30

10.  Cathepsin B as a potential cystatin M/E target in the mouse hair follicle.

Authors:  Merel A W Oortveld; Ivonne M J J van Vlijmen-Willems; Ferry F J Kersten; Tsing Cheng; Martijn Verdoes; Piet E J van Erp; Sjef Verbeek; Thomas Reinheckel; Wiljan J A J Hendriks; Joost Schalkwijk; Patrick L J M Zeeuwen
Journal:  FASEB J       Date:  2017-06-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.